µÏÍþ¹ú¼Ê

µÏÍþÖÆµÏÍþ¹ú¼Ê µÏÍþÖÆµÏÍþ¹ú¼Ê

¼ò ¤™
  • ¼ò
  • ·±
  • EN
¤œ
Ïà¹ØÁ´½Ó
  • ½­ËÕºÀÉ­µÏÍþ¹ú¼ÊÒµ¼¯ÍÅÓÐÏÞ¹«Ë¾¥Y
ÐÂÎÅ·¢²¼
Press Release
Ê×Ò³  >  ÐÂÎÅÖÐÐÄ  >  ÐÂÎÅ·¢²¼
µÏÍþÖÆµÏÍþ¹ú¼ÊÖ§³ÖÉèÁ¢¡°¹ú¼ÊÊÓÉñ¾­¼¹ËèÑ×ÈÕ¡±²¢ÔÚ¾©¾ÙÐÐÖ÷Ìâ»î¶¯
·¢²¼ÈÕÆÚ£º2024/10/30
×ÖºÅ
ͼƬ

2024Äê10ÔÂ26ÈÕ£¬ÓɹãÖÝÊкìÃÞÖ×ÁöºÍº±¼û²¡¹«Òæ»ù½ð»á¡¢¶àÉñ¼ÒÔ°¹²Í¬·¢Æð£¬µÏÍþÖÆµÏÍþ¹ú¼ÊÖ§³ÖµÄ¡°¹ú¼ÊÊÓÉñ¾­¼¹ËèÑ×ÈÕ¡± Ö÷Ìâ»î¶¯ÔÚ¾©¾ÙÐС£»áÉÏÐû²¼½«Ã¿Äê10ÔÂ26ÈÕÉèΪ¡°¹ú¼ÊÊÓÉñ¾­¼¹ËèÑ×ÈÕ¡±£¬ÒÔ½øÒ»²½ÌáÉý¹«ÖÚ¶ÔÊÓÉñ¾­¼¹ËèÑׯ×ϵ¼²²¡£¨NMOSD£©µÄ¹Ø×¢ºÍÈÏÖª¡£



ҽѧר¼Ò¡¢¹«Òæ×éÖ¯¸ºÔðÈ˹²Í¬Îª¡°¹ú¼ÊÊÓÉñ¾­¼¹ËèÑ×ÈÕ¡±½ÒÄ»

À´×Ô±±¾©¡¢Ìì½ò¡¢ÖØÇì¡¢Çൺ¡¢ÐìÖݵȵصÄÖªÃûNMOSDҽѧר¼Ò£¬¹«Òæ×éÖ¯¸ºÔðÈËÒÔ¼°»¼Õß´ú±í¹²Í¬¼ûÖ¤ÁË¡°¹ú¼ÊÊÓÉñ¾­¼¹ËèÑ×ÈÕ¡±µÄÉèÁ¢¡£ÔÚËæºóµÄ·ÖÏí»·½ÚÖУ¬NMOSD»¼Õß´ú±í½áºÏ×ÔÉí¾­Àú£¬½²ÊöÁËNMOSD´Ó·¢²¡µ½È·Õï¡¢ÖÎÁÆ£¬ÔÙµ½¶Ô¿¹¸´·¢µÄÀú³Ì£¬¹ÄÀø¸ü¶à»¼Õ߼ᶨÐÅÐÄ£¬»ý¼«ÖÎÁÆ£¬×îÖÕ×ßÏòÐÂÉú¡£NMOSDҽѧר¼ÒÏÖ³¡·ÖÏíÁËNMOSDÁìÓò×îеĿÆÑнøÕ¹£¬Í¬Ê±Ç¿µ÷ÁËÔçÕïÔçÖΡ¢³¤ÆÚÖÎÁÆ¡¢Ô¤·À¸´·¢µÄÖÎÁÆÀíÄî¡£

ҽѧר¼ÒÏÖ³¡½éÉÜ×îпÆÑнøÕ¹£¬½â´ð»¼ÕßÒÉ»ó

NMOSDÊÇÒ»ÖÖº±¼û¡¢¸ß¸´·¢¡¢¸ßÖ²еÄÖÐÊàÉñ¾­ÏµÍ³×ÔÉíÃâÒßÐÔ¼²²¡£¬ÒÔÊÓÉñ¾­ºÍ¼¹ËèµÄÑ×ÐÔ²¡±äÎªÌØÕ÷£¬»¼ÕßÒ׳öÏÖÊÓÎïÄ£ºý¡¢Ì±»¾¡¢ÌÛÍ´¡¢ÐÐ×ßÀ§ÄÑ¡¢Í·ÔΡ¢Å»ÍµÈÖ¢×´£¬ºÃ·¢ÓÚÇà׳Ä꣬ŮÐԾӶ࣬¼«Ò׸´·¢¡£2018Ä꣬NMOSD±»ÁÐÈë¡¶ÖйúµÚÒ»Åúº±¼û²¡Ä¿Â¼¡·¡£

Ô¢Òâ¡°¹Ø°®¡¢¹âÃ÷¡¢Ï£Íû¡±µÄ¡°¹ú¼ÊÊÓÉñ¾­¼¹ËèÑ×ÈÕ¡±Æ·ÅƱêʶ

Óë´ó¶àÊýº±¼û²¡Çé¿öÀàËÆ£¬ÎÒ¹úNMOSD»¼ÕßÒ²Ò»¶ÈÃæÁÙȱÉÙÊÊÓ¦Ö¢ÓõÏÍþ¹ú¼ÊµÄÀ§¾³£¬ÖÂʹËûÃdz¤ÆÚÉú»îÔÚ¼²²¡¸´·¢¡¢ÉíÌåÖ²еĿ־åÖС£Òò²¡Ê§Òµ¡¢Ê§Ñ§ÔÚNMOSD»¼ÕßȺÌåÖÐÆÄΪ³£¼û£¬½ø¶øÑÏÖØÓ°Ï컼Õß¼°Æä¼ÒÍ¥µÄÕý³£Éú»î¡£

2022Äê3Ô£¬µÏÍþÖÆµÏÍþ¹ú¼ÊºÏ×÷Òý½øµÄÐÂÐ͸ßЧÉúÎïÖÆ¼ÁÒÁÄÎÀûÖéµ¥¿¹ÔÚÎÒ¹ú»ñÅúÉÏÊУ¬ÓÃÓÚ¿¹AQP4¿¹ÌåÑôÐÔµÄNMOSD³ÉÈË»¼ÕßÖÎÁÆ£»2023Äê3Ô£¬ÒÁÄÎÀûÖéµ¥¿¹±»ÄÉÈë¹ú¼ÒÒ½±££¬³ÉΪÎÒ¹úÊ׸öNMOSDÒ½±£ÓõÏÍþ¹ú¼Ê£¬¡°¾³ÄÚÎÞµÏÍþ¹ú¼Ê¡¢³¬ÊÊÓ¦Ö¢ÓõÏÍþ¹ú¼Ê¡¢µÏÍþ¹ú¼ÊÎïδÄÉÈëÒ½±£¡±µÈÕïÁÆÀ§¾³±»Ò»¾Ù´òÆÆ¡£

ºËÐÄÑо¿ÏÔʾ£¬ÒÁÄÎÀûÖéµ¥¿¹½µµÍAQP4-IgGÑôÐÔ»¼Õß·¢×÷·çÏյķù¶È´ï77%£»½ÓÊÜÒÁÄÎÀûÖéµ¥¿¹ÖÎÁÆÒ»Äêºó£¬92%»¼Õß¿ÉÔÚºóÐøÊ±¼ä³ÖÐøÎÞ·¢×÷[1]¡£´ËÍ⣬ÒÁÄÎÀûÖéµ¥¿¹Ã¿°ëÄêÒ»´ÎµÄ¸øµÏÍþ¹ú¼ÊƵÂÊÄÜ×î´óÏ޶ȵرÜÃâÓõÏÍþ¹ú¼Ê¶Ô»¼ÕßÕý³£Éú»îÐγɸÉÈÅ£¬ÎªÐèÒª³¤ÆÚÓõÏÍþ¹ú¼ÊµÄNMOSD»¼ÕßÌṩÁ˸üΪÓѺõÄÖÎÁÆÑ¡Ôñ£¬Ê¹ÖйúNMOSDÓ­À´ÉúÎïÖÆ¼ÁÖÎÁÆÐÂʱ´ú¡£

²Î¿¼ÎÄÏ×£º

[1] Bruce A C Cree, et al. Lancet. 2019 Oct 12;394(10206):1352-1363.


¹ØÓÚµÏÍþ

µÏÍþÖÆµÏÍþ¹ú¼ÊÊÇÖйúÁìÏȵĴ´ÐÂÇý¶¯ÐÍÖÆµÏÍþ¹ú¼ÊÆóÒµ£¬ÏÂÊôºÀÉ­µÏÍþ¹ú¼ÊÒµ¡¢³£Öݺã°îµÏÍþ¹ú¼ÊÒµ¡¢µÏÍþÉúÎïÒ½µÏÍþ¹ú¼ÊµÈ×Ó¹«Ë¾£¬ÖØµã¹Ø×¢¿¹Ö×Áö¡¢¿¹¸ÐȾ¡¢ÖÐÊàÉñ¾­ÏµÍ³¡¢´úл¼°×ÔÉíÃâÒßµÈÖØ´ó¼²²¡ÖÎÁÆÁìÓò£¬ÖÂÁ¦ÓÚͨ¹ý³ÖÐø´´ÐÂÌá¸ßÈËÀàÉúÃüÖÊÁ¿¡£½ØÖÁ2024ÉϰëÄ꣬¹«Ë¾ÒÑÉÏÊÐ7¿î´´ÐµÏÍþ¹ú¼Ê£¬´´Ð²úÆ·ÓªÊÕÕ¼±È´ï77.4%¡£¹«Ë¾Á¬Ðø¶àÄêλ¾ÓÈ«ÇòÖÆµÏÍþ¹ú¼ÊÆóÒµ°ÙÇ¿¡¢ÖйúÒ½µÏÍþ¹ú¼ÊÑз¢²úÆ·Ïß×î¼Ñ¹¤ÒµÆóҵǰ3Ç¿£¬Êǹú¼ÒÖØµã¸ßм¼ÊõÆóÒµ¡¢¹ú¼Ò¼¼Êõ´´ÐÂʾ·¶ÆóÒµ¡£¹«Ë¾ÓÚ2019Äê6ÔÂÔÚÏã¸ÛÁª½»Ëù¹ÒÅÆÉÏÊУ¨¹ÉƱ´úÂ룺03692.HK£©¡£¸ü¶àÐÅÏ¢Çë·ÃÎÊ£º/¡£


ÉùÃ÷£º
1¡¢µÏÍþÖÆµÏÍþ¹ú¼Ê²»ÍƼöÈκÎδ»ñÅúµÏÍþ¹ú¼ÊƷʹÓûòδ»ñÅúÊÊÓ¦Ö¢ÓõÏÍþ¹ú¼Ê¡£

2¡¢±¾ÐÂΟåÖеÄÒ½ÁÆÐÅÏ¢½ö¹©ÐÅÏ¢ºÍÐÂÎű¨µÀʹÓ㬲»ÓÃÓÚ¹ã¸æÄ¿µÄ£¬²»Òª½«ÆäÓÃÓÚÒ½ÁƱ£½¡»òÕï¶Ï½¨Òé¡£


ǰհÐÔ˵Ã÷

±¾ÐÂΟåÖ¼ÔÚÌṩ¹ØÓÚµÏÍþÖÆµÏÍþ¹ú¼Ê¼¯ÍÅÓÐÏÞ¹«Ë¾¼°Æä¸½Êô¹«Ë¾£¨°üÀ¨Æä×Ó¹«Ë¾£¬Í³³ÆÎª¡°µÏÍþÖÆµÏÍþ¹ú¼Ê¡±£©µÄÐÅÏ¢¡£Ëü²»¹¹³É¶ÔµÏÍþÖÆµÏÍþ¹ú¼Ê»òÈκÎͶ×ʽ¨ÒéµÄÐÅÏ¢Åû¶¡£

±¾ÐÂΟå°üº¬µÄÐÅÏ¢¿ÉÄܰüÀ¨ÓëµÏÍþÖÆµÏÍþ¹ú¼ÊÒµÎñºÍ²úƷǰ¾°¡¢¼Æ»®¡¢ÐÅÄî¡¢Ô¤ÆÚºÍ²ßÂÔÏà¹ØµÄǰհÐÔÉùÃ÷¡£ÕâЩÉùÃ÷ÊÇ»ùÓÚÍÆ²âÐÔ¼ÙÉèµÄÔ¤²â£¬²¢²»±£Ö¤Î´À´µÄ±íÏÖ¡£ËüÃÇÊܵ½ÖîÈç¿ÆÑ§¡¢ÉÌÒµ¡¢ÕþÖΡ¢¾­¼Ã¡¢²ÆÎñ¡¢·¨ÂÉÒòËØÒÔ¼°¾ºÕù»·¾³ºÍÉç»áÌõ¼þµÈ·çÏպͲ»È·¶¨ÐÔµÄÓ°Ï죬ÕâЩÒòËØºÜ¶à¶¼ÊǵÏÍþÖÆµÏÍþ¹ú¼ÊÎÞ·¨¿ØÖÆÇÒÄÑÒÔÔ¤²âµÄ£¬Òò´Ëʵ¼Ê½á¹û¿ÉÄÜÓë´Ë´¦ËùÊöÓÐÏÔÖø²îÒ죬ÇÒ¹ýÈ¥µÄ֤ȯ¼Û¸ñÇ÷ÊÆ²»Ó¦×÷ΪδÀ´ÐÐÇéµÄÖ¸µ¼¡£Òò´Ë£¬Í¶×ÊÕßÔÚʹÓÃÕâЩÐÅÏ¢½øÐÐͶ×ʾö²ßʱӦ½÷É÷ÐÐÊ¡£¡°ÖÂÁ¦ÓÚ¡±¡°Ô¤ÆÚ¡±¡°ÏàÐÅ¡±¡°Ô¤²â¡±¡°Òâͼ¡±¡°Ô¤¼Æ¡±¡°¿ÉÄÜ¡±¡°½«¡±¡°Ó¦¸Ã¡±¡°¼Æ»®¡±¡°¼ÌÐø¡±¡°Ä¿±ê¡±¡°¿¼ÂÇ¡±¡°¹À¼Æ¡±¡°Ö¸µ¼¡±¡°Ç±ÔÚ¡±¡°×·Çó¡±ÒÔ¼°ÓÚÈκÎδÀ´¼Æ»®¡¢Ðж¯»òʼþµÄÌÖÂÛÖÐʹÓõÄÀàËÆ´ÊÓïºÍÊõÓ¾ù±íʾǰհÐÔÉùÃ÷¡£

µÏÍþÖÆµÏÍþ¹ú¼Ê²»³Ðŵ»ò±£Ö¤Ç°Õ°ÐÔÐÅÏ¢µÄ׼ȷÐÔ¡¢¼°Ê±ÐÔ»òÍêÕûÐÔ£¬²¢ÇÒ²»³Ðµ£¸üлòÐÞ¶©ÕâЩǰհÐÔÉùÃ÷µÄÒåÎñ¡£ÎÞÂÛÊǵÏÍþÖÆµÏÍþ¹ú¼Ê»¹ÊÇÆäÈκζ­Ê¡¢Ô±¹¤»ò´úÀíÈË£¬¾ù²»¶ÔÈκÎÖ¤Ã÷²»×¼È·»òÎÞ·¨ÊµÏÖµÄǰհÐÔÉùÃ÷¸ºÔð£¬Ò²²»¶ÔÒòÒÀÀµ±¾ÐÂΟåÖÐÌṩµÄÐÅÏ¢¶ø²úÉúµÄÈκÎËðʧ»òË𺦸ºÔ𣬰üÀ¨µ«²»ÏÞÓÚÖ±½Ó¡¢Å¼È»¡¢¼ä½Ó»ò³Í·£ÐÔµÄË𺦡£

±¾ÐÂΟåÖеÄËùÓÐÐÅÏ¢¾ùΪ·¢²¼Ö®ÈÕµÄ×îÐÂÐÅÏ¢¡£µÏÍþÖÆµÏÍþ¹ú¼Ê²»³Ðµ£Òòз¢Õ¹¡¢Î´À´Ê¼þ»òÆäËûÇé¿ö¶ø¸üлòÐÞ¶©ÕâЩÐÅÏ¢µÄÔðÈΣ¬³ý·Ç·¨ÂÉÒªÇó¡£´ËÍ⣬µÏÍþÖÆµÏÍþ¹ú¼Ê±£ÁôÔÚÈκÎʱºòδ¾­Í¨Öª¶Ô±¾ÐÂΟåµÄÈ«²¿»ò²¿·ÖÄÚÈݽøÐиü¸Ä¡¢¸üÕý»òÖжϵÄȨÀû¡£¶ÔÓÚÌØ±ðÓëÉÏÊй«Ë¾ÓйصÄÐÅÏ¢£¬¹«Ë¾¹ÄÀøÍ¶×ÊÕ߲ο¼µÏÍþÖÆµÏÍþ¹ú¼Ê£¨03692.HK£©µÄ¹«¸æºÍ²ÆÎñ±¨¸æ¡£

  • ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿